procyanidin has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
| Studies (procyanidin) | Trials (procyanidin) | Recent Studies (post-2010) (procyanidin) | Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) |
|---|---|---|---|---|---|
| 4,116 | 136 | 2,747 | 3,859 | 8 | 1,052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; He, P; Jiao, J; Li, S; Liu, C; Lv, Y; Mao, X; Xu, J; Xue, X | 1 |
1 other study(ies) available for procyanidin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Proanthocyanidins exert a neuroprotective effect via ROS/JNK signaling in MPTP‑induced Parkinson's disease models in vitro and in vivo.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apoptosis; Cell Proliferation; Cell Survival; Disease Models, Animal; Dopaminergic Neurons; JNK Mitogen-Activated Protein Kinases; Male; Matrix Metalloproteinases; Membrane Potential, Mitochondrial; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; PC12 Cells; Proanthocyanidins; Rats; Reactive Oxygen Species; Signal Transduction | 2018 |